Cargando…
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
Background: During the past years biologic agents (also termed biologicals or biologics) have become a crucial treatment option in immunological diseases. Numerous articles have been published on biologicals, which complicates the decision making process on the use of the most appropriate biologic f...
Autores principales: | Kaegi, Celine, Wuest, Benjamin, Schreiner, Jens, Steiner, Urs C., Vultaggio, Alessandra, Matucci, Andrea, Crowley, Catherine, Boyman, Onur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743223/ https://www.ncbi.nlm.nih.gov/pubmed/31555262 http://dx.doi.org/10.3389/fimmu.2019.01990 |
Ejemplares similares
-
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2020) -
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2022) -
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
por: Arnold, Dennis D., et al.
Publicado: (2022) -
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
por: Matucci, Andrea, et al.
Publicado: (2018) -
Mechanisms of Action of Ig Preparations: Immunomodulatory and Anti-Inflammatory Effects
por: Matucci, Andrea, et al.
Publicado: (2015)